CliffBio

Maia

Patent cliffs & loss of exclusivity

MAIA is the first decentralized reserve currency in Metis Andromeda. Different strategies will be applied in order to incentivize treasury growth, starting by the selective expansion of the bonds available, as well as, APY management and partnerships with other DAOs.

Company

Block Explorer URLhttps://andromeda-explorer.metis.io/token/0x72c232D56542Ba082592DEE7C77b1C6CFA758BCD/token-transfers
CoinMarketCap URLhttps://coinmarketcap.com/currencies/maia/
Contact Page URLhttps://andromeda-explorer.metis.io/token/0x72c232D56542Ba082592DEE7C77b1C6CFA758BCD/token-transfers
Cryptocurrency SymbolMAIA
Discord URLhttps://discord.gg/7hXXFRC8Wv
GitHub URLhttps://github.com/MaiaDAO
Medium URLhttps://medium.com/@maiaDAO
Ticker SymbolMAIA

4 upcoming patent cliffs

DrugIngredientTypeCliff
  1. SINCALIDESINCALIDESmall mol.Apr 2038
  2. ANGIOMAX RTUBIVALIRUDINSmall mol.May 2039
  3. BORTEZOMIBBORTEZOMIBSmall mol.Sep 2042
  4. BORTEZOMIBBORTEZOMIBSmall mol.Sep 2042
  5. BACLOFENBACLOFENSmall mol.—
  6. BACLOFENBACLOFENSmall mol.—
  7. BACLOFENBACLOFENSmall mol.—
  8. BACLOFENBACLOFENSmall mol.—
  9. DAPTOMYCINDAPTOMYCINSmall mol.—
  10. DAPTOMYCINDAPTOMYCINSmall mol.—
  11. LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMSmall mol.—
  12. LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMSmall mol.—
  13. LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMSmall mol.—
  14. SODIUM PHENYLACETATE AND SODIUM BENZOATESODIUM BENZOATE; SODIUM PHENYLACETATESmall mol.—
  15. SODIUM PHENYLACETATE AND SODIUM BENZOATESODIUM BENZOATE; SODIUM PHENYLACETATESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Maia — patent cliffs & loss of exclusivity | CliffBio